CEA [CHINA EASTERN AIRLINES] 6-K: (Original Filing)
[]
LITB [LightInTheBox] 6-K: (Original Filing)
[LightInTheBox Holding Co., Ltd. Responds to Class Action Lawsuit The Company has reviewed the claims asserted in the complaint and believes that they are without merit. While the Company has not yet been served with a copy of the complaint, it intends to work with Simpson Thacher & Bartlett LLP, its legal counsel, to vigorously defend itself in this matter.]
LITB [LightInTheBox] 6-K: LightInTheBox Holding Co., Ltd. Responds to Class Action
[LightInTheBox Holding Co., Ltd. Responds to Class Action Lawsuit The Company has reviewed the claims asserted in the complaint and believes that they are without merit. While the Company has not yet been served with a copy of the complaint, it intends to work with Simpson Thacher & Bartlett LLP, its legal counsel, to vigorously defend itself in this matter.]
BSPM [Biostar Pharmaceuticals,] S-8: (Original Filing)
[FORM S-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT UNDER THE Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 including zip code) (Full title of the plan) Ronghua Wang, President and Chief Executive Officer No. 588 Shiji Xi Avenue,] [Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan This Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee] [[Schiff Hardin letterhead] August 28, 2013 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China Ladies and Gentlemen: Schiff Hardin LLP EX-5.1 3 ex5-1.htm] [Consent of Independent Registered Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated August 28, 2013 of Biostar Pharmaceuticals, Inc. of our report dated April 11, 2013 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Certified Public Accountants Hong Kong August 28, 2013 EX-23.2 5 ex23-2.htm]
BSPM [Biostar Pharmaceuticals,] S-8: FORM S-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT
[FORM S-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT UNDER THE Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 including zip code) (Full title of the plan) Ronghua Wang, President and Chief Executive Officer No. 588 Shiji Xi Avenue,] [Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan This Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee] [[Schiff Hardin letterhead] August 28, 2013 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China Ladies and Gentlemen: Schiff Hardin LLP EX-5.1 3 ex5-1.htm] [Consent of Independent Registered Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated August 28, 2013 of Biostar Pharmaceuticals, Inc. of our report dated April 11, 2013 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Certified Public Accountants Hong Kong August 28, 2013 EX-23.2 5 ex23-2.htm]
LITB [LightInTheBox] 6-K: LightInTheBox Responds to Class Action Lawsuit Thempany has
[LightInTheBox Responds to Class Action Lawsuit Thempany has reviewed the claimsserted in themplaint and believes that they are without merit. While thempany has not yet been served with apy of themplaint, it intends to work with Simpson Thacher & Bartlett its legalunsel, to vigorously defend itself in this matter.]
CMGE [China Mobile Games & Entertainment] 6-K: CMGE Reports Second Quarter 2013 Unaudited Financial Results
[CMGE Reports Second Quarter 2013 Unaudited Financial Results HONG KONG, August 28, 2013 China Mobile Games and Entertainment Group Limited (CMGE or the Company) (Nasdaq: CMGE), a leading mobile game company in China, today reported its unaudited financial results for the second quarter ended Second Quarter 2013 Financial Highlights Revenues were RMB72.0 million (US$11.7 million 1 ), 18.6%] [China Mobile Games and Entertainment Group Limited Description]
HNP [HUANENG POWER INTERNATIONAL] 6-K: (Original Filing)
[This Form 6-K consists of: Contents 2 Interim Results 2 Business Review for the First Half of the Year 3 Prospects for the Second Half of 2013 3 Management’s Discussion and Analysis (Prepared Under IFRS) 12 Share Capital Structure 12 Purchase, Sale or Redemption of Shares 12 Major Shareholding Structure 13 Material Interests and Short Positions in Shares and Underlying]
BSPM [Biostar Pharmaceuticals,] S-8: (Original Filing)
[FORMS-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT UNDER THE Biostar Pharmaceuticals, Maryland (State or other jurisdiction oforporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China 712046luding zipde) (Full title of the plan) Ronghua Wang, President and Chief Executive Officer] [Biostar Pharmaceuticals, 2012 Stock Optionmpensation Plan This Biostar Pharmaceuticals, 2012 Stock Optionmpensation Plan Plan 1. Definitions. (a) Board " (b)de " (c)mmittee Rule 16b-3 Exchange Act " (d)mpany " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grantreement] [[Schiff Hardin letterhead] August 28, 2013 Biostar Pharmaceuticals, No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China Ladies and Gentlemen:hiff Hardin ex5-1.htm 3 EX-5.1] [Consent of Independent Registered Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, We herebynsent to theorporation by reference in the Registration Statement on Form S-8ted August 28, 2013 of Biostar Pharmaceuticals, of our reportted April 11, 2013 relating to thensolidated financial statements, which appears in the Annual Report on Form 10-K of Biostar] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Certified Public Accountants Hong Kong August 28, 2013 ex23-2.htm 5 EX-23.2]
QIHU [Qihoo 360 Technology Co] 6-K: (Original Filing)
[Qihoo 360 Technology Co. Ltd. Announces Offering of US$550 Million BEIJING, Aug. 27, 2013 -- Qihoo 360 Technology Co. Ltd. ("Qihoo 360" or the "Company") (NYSE: QIHU) today announced that it plans to offer US$550 million principal amount of convertible senior notes due 2018, subject to market conditions and other factors. Qihoo 360 plans to grant the initial purchasers of] [Technology Co. Ltd. Prices Offering of US$550 Million of Qihoo 360 The notes will be convertible into Qihoo 360’s American Depositary Shares (“ADSs”), every two ADSs representing as of the date above three Class A ordinary shares of Qihoo 360, based on an initial conversion rate of 9.0119 ADSs per US$1,000 principal amount of the notes (equivalent to an initial] []
